Natco Pharma Ltd.

Natco Pharma has received board’s approval to acquire Dash Pharmaceuticals LLC, USA through one of its subsidiary Company. Dash is a front-end pharmaceutical sales, marketing and distribution entity based in New Jersey, USA which is expected to have approximate net sales of $15 million for the year ending December 2021. This acquisition provides Natco with a front-end to engage with its customers directly in the USA which is the largest pharmaceutical market in the world. The Board of Directors of the company at their meeting held on December 14, 2021 has considered and approved the same. 

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.